Takara Bio Inc.
Investor Relations

Investor Relations

Investor Relations

Message from the President

Message from the President

Medium/Long-Term
Management Plan

Medium/Long-Term <br>Management Plan

Latest Financial Statement

Financial Results
parts_max: 1

IR Event

2025/5/13
Financial results for FY ended March 31, 2025

IR Calendar

Corporate Introduction

Latest report

Consolidated Financial Results for the FY Ended March 31 2025 （477KB）
　
Click here for back numbers

IR News

2025/05/13 Notice of Changes in Representative Directors （140KB）
2025/05/13 Notice Concerning Dividend from Surplus （137KB）
2025/05/13 Consolidated Financial Results for the FY Ended March 31 2025 （478KB）
2025/05/01 (Progress of Matters Previously Disclosed) Notice Concerning the Absorption-type Merger (Simplified Merger) of the Wholly Owned Subsidiary （233KB）
2025/03/28 [Delayed] Notice Concerning the Absorption-type Merger (Simplified Merger) of the Wholly Owned Subsidiary （267KB）

Read More

Management Policy

Financial Data

IR Library

Stock Information

IR Calendar

FAQ

Contact IR

Disclosure Policy

User Guide

CLOSE
MENU

サイト内検索

footer-content

menu

JA
EN

contact

gnavi-box